These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 14496660)

  • 1. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
    SAMPEY JR
    J S C Med Assoc (Columbia); 1962 May; 58():175-6. PubMed ID: 14496660
    [No Abstract]   [Full Text] [Related]  

  • 2. [A severe case of lymphographylomatosis successfully treated with dopan].
    POSLAVSKII EV; LEKSIKOV IM
    Probl Gematol Pereliv Krovi; 1959 Dec; 4():45-6. PubMed ID: 14434366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol].
    RAEVSKII IG
    Vopr Onkol; 1962; 8(4)():3-11. PubMed ID: 14489811
    [No Abstract]   [Full Text] [Related]  

  • 4. New nitrogen mustards in the management of Hodgkin's disease.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1960 Jun; 132():231-8. PubMed ID: 14441250
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
    THEOLOGIDES A; KENNEDY BJ
    Minn Med; 1962 Feb; 45():165-8. PubMed ID: 13920550
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitrogen mustard treatment of Hodgkin's disease.
    TUCKER HS; KAY WR
    Va Med Mon (1918); 1949 Oct; 76(10):502-10. PubMed ID: 18140990
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitrogen mustard therapy with special reference to Hodgkin's disease.
    NABARRO JD
    Br Med J; 1949 Sep; 2(4628):622-5. PubMed ID: 18140561
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitrogen mustards in the management of Hodgkin's disease and the leukemias. VII. Clinical reports, 1959-62.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1962 Oct; 134():374-88. PubMed ID: 13976141
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of Hodgkin's disease by short cures with nitrogen mustards. Apropos of 15 cases].
    ROUSSO C
    Helv Med Acta; 1961 Mar; 28():99-126. PubMed ID: 13744034
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitrogen mustards in the management of Hodgkin's disease and the leukemias. IX. Further clinical reports, 1960-1962.
    SAMPEY JR
    J S C Med Assoc (Columbia); 1963 Aug; 59():272-4. PubMed ID: 13976136
    [No Abstract]   [Full Text] [Related]  

  • 12. Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets.
    CONRAD ME; CROSBY WH
    Blood; 1960 Aug; 16():1089-103. PubMed ID: 13811574
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined radiation and nitrogen mustrad therapy in Hodgkin's disease as compared with radiation therapy alone.
    COOK JC; KRABBENHOFT KL; LEUCUTIA T
    Am J Roentgenol Radium Ther Nucl Med; 1959 Oct; 82():651-7. PubMed ID: 13811703
    [No Abstract]   [Full Text] [Related]  

  • 14. Uracil mustard therapy in acute leukemia in children.
    PORTER FS; HOLOWACH J; THURMAN WG
    Cancer Chemother Rep; 1962 May; 18():79-82. PubMed ID: 14488068
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of the effect of degranol.
    SANDOR L; CERNY V; UJHAZY V; WINKLER A
    Neoplasma; 1959; 6():179-82. PubMed ID: 14441442
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of malignant lymphomas and lymphadenoses with leukeran.
    LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J
    Neoplasma; 1959; 6():415-24. PubMed ID: 14416684
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial of a new nitrogen-mustard compound.
    SELLEI C; ECKHARDT S; HARTAI F; DUMBOVICH B
    Lancet; 1956 May; 270(6926):785-6. PubMed ID: 13320884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hematologic neoplasms with nitrogen oxide mustards].
    HORLIN W; SCHMITT W
    Dtsch Med Wochenschr; 1957 Feb; 82(7):247-50. PubMed ID: 13427484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia].
    RAMIOUL H
    Acta Unio Int Contra Cancrum; 1955; 11(2):167-9. PubMed ID: 13248724
    [No Abstract]   [Full Text] [Related]  

  • 20. A quantitative evaluation of the contribution of nitrogen mustard to the therapeutic management of Hodgkin's disease.
    GELLHORN A; COLLINS VP
    Ann Intern Med; 1951 Dec; 35(6):1250-9. PubMed ID: 14895004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.